GlassScriptPhysician profile
Katie L Hare
NPI 1457768483
$4,631.53
in general payments reported to CMS, 2019-2025
19 companies · $1,445 in 2025
The $1,445 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $567 · 2022: $1,312 · 2023: $659 · 2024: $648 · 2025: $1,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,319 · Education: $258 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,319.32 |
| Education | $257.99 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,249.82 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Pfizer INC. | $794.32 | 2021-2025 | |
| Amgen INC. | $507.98 | 2021-2025 | Prolia, Tavneos, Evenity |
| Abbvie INC. | $387.67 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $366.63 | 2021-2025 | Saphnelo |
| Glaxosmithkline, LLC. | $265.78 | 2022-2025 | Benlysta |
| Novartis Pharmaceuticals Corporation | $248.62 | 2021-2025 | |
| Genzyme Corporation | $235.26 | 2024-2025 | |
| Lilly USA, LLC | $126.41 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $125.00 | 2022 | |
| Sanofi-Aventis U.S. LLC | $79.99 | 2025 | |
| Allergan, INC. | $50.10 | 2022 | |
| Genentech USA, INC. | $32.61 | 2025 | Gazyva |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.53 | 2022 | |
| Ucb, INC. | $29.04 | 2025 | Bimzelx |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $25.42 | 2021 | |
| Invivyd INC | $25.15 | 2025 | Pemgarda |
| Daiichi Sankyo INC. | $24.60 | 2025 | Injectafer |
| Octapharma USA, INC. | $24.60 | 2025 | Octagam Immune Globulin (Human) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Hare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.